MICHAEL THOMPSON: Open Payments
NPI 1215914718 · SOMERSWORTH, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 10 payments from 8 companies in 2025. Trend: 2023 $43 · 2024 $180 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| Baxter Healthcare | 1 | $61 |
| Gilead Sciences, Inc. | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 1 | $40 |
| ABBVIE INC. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| PFIZER INC. | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
Products named: Hillrom - Carnation Ambulatory Monitor, FANAPT, VRAYLAR, CAPLYTA, MOUNJARO, PAXLOVID, Ozempic.
Industry payments across NH — which companies pay providers there.
